STK-009

N/A

Report date: 2024/09/05 09:09:23

Base Information

Drug NameSTK-009
Drug Alias NameSTK-009
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 receptor beta chain agonists
TargetsInterleukin-2 receptor beta chain
Therapy Area/IndicationsScleroderma, SystemicLupus Erythematosus, SystemicLupus Nephritis +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynthekine Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynthekine Inc
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicLupus Erythematosus, SystemicLupus Nephritis +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A